Animal Antimicrobials and Antibiotics Market Is Booming Worldwide | Merck & Co., Inc., Zoetis, Inc., Bayer AG, Virbac, Eli Lilly Company, Boehringer Ingelheim GmbH, Vetoquinol S.A., Ceva Sante Animale, Dechra Pharmaceuticals PLC

The rising demand for livestock products, owing to increasing population of livestock throughout the world is likely to boost growth of the animal antimicrobials and antibiotics market. Moreover, the rising incidence of diseases in livestock is likely to aid in the expansion of this market. However, the use of in-feed enzymes and stringent regulations are limiting the growth of this market. Another factor boosting the overall growth of the market is the growing demand for animal proteins and the increasing trend of pet ownership. The growing incidences of animal disease epidemics, rising population of livestock and favorable economic conditions of emerging economies including China, Brazil, and India, are encouraging the growth of this market.

Get Exclusive Sample Copy @ www.coherentmarketinsights.com/insight/request-sample/522

On the other hand, some factors including the augmented administration of in-feed enzymes, firm regulatory policies in the field and increased use of substitute medicines including prebiotics are likely to restrain the growth of the overall animal antimicrobials and antibiotics market during the forecast period.

The antimicrobial and antibiotic products have considerable benefits to the animal as well as to human food safety. Researchers have shown that a rise in the rate of animal illness invariably results into higher rate of illness among humans. Hence, livestock traders depend primarily on animal antibiotics to offer safe food. Another factor driving the market is the rising demand for meat, milk, and other animal food products. The profound usage of various types of meats and a variety of milk in the dairy products, especially in the western diet and the speedy adoption of these eating habits across the globe are expected to lead to a rise in demand for animal antimicrobials and antibiotics around the globe. These factors will fuel the growth of the animal antimicrobials and antibiotics market in the near future.

On the other hand, some factors including the augmented administration of in-feed enzymes, firm regulatory policies in the field and increased use of substitute medicines including prebiotics are likely to restrain the growth of the overall animal antimicrobials and antibiotics market during the forecast period.

The key market players operating in the global animal antimicrobials and antibiotics market are Merck & Co., Inc., Zoetis, Inc., Bayer AG, Virbac, Eli Lilly Company, Boehringer Ingelheim GmbH, Vetoquinol S.A., Ceva Sante Animale, Dechra Pharmaceuticals PLC and Sanofi.

Get Discount @ www.coherentmarketinsights.com/insight/request-discount/522

Animal antimicrobials and antibiotics market Taxonomy

On the basis of type of product,

Penicillin
Tetracycline
Sulfonamides
Quinolones
Macrolides
Cephalosporin
Amingoglycoside
Others
On the basis of type of animals,

Companion animals
Food-producing animals
On the basis of mode of delivery,

Oral powder or solutions
Injections
Premix
Others

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.